S. V. Dullemen

Dynamics of abdominal symptoms during the start of a new therapy with Elexacaftor/Tezacaftor/Ivacaftor using the novel CFAbd-day2day questionnaire

J. Mainz, O. Eickmeier, C. Schwarz, 2023, medRxiv.

Body composition, muscle strength and hormonal status in patients with ataxia telangiectasia: a cohort study

R. Schubert, S. Zielen, M. Kieslich, 2015, Orphanet Journal of Rare Diseases.